½ÃÀ庸°í¼­
»óǰÄÚµå
1608867

¼ÒžÆÇ÷û ½ÃÀå : ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Fetal Bovine Serum Market, By Application, By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, and Others), By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼ÒžÆÇ÷û ½ÃÀåÀº 2024³â 18¾ï 6,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç 2031³â¿¡´Â 45¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 13.6%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÐ¼® ¹üÀ§ ºÐ¼® »ó¼¼
±âÁØ ¿¬µµ 2023³â ½ÃÀå ±Ô¸ð(2024³â) 18¾ï 6,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2019-2023³â ¿¹Ãø ±â°£ 2024-2031³â
¿¹Ãø ±â°£ÀÇ CAGR(2024-2031³â) 13.60% ¿¹Ãø ±Ý¾×(2031³â) 45¾ï 4,000¸¸ ´Þ·¯
±×¸² : ¼ÒžÆÇ÷û ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2024³â
Fetal Bovine Serum Market-IMG1

¼ÒžÆÇ÷ûÀº °úÇÐ ¿¬±¸ ¹× ´Ù¾çÇÑ ÀÇ·á °úÁ¤¿¡ »ç¿ëµÇ´Â Áß¿äÇÑ ¼¼Æ÷¹è¾ç ¹èÁö º¸ÃæÁ¦ÀÔ´Ï´Ù. žÆÇ÷û(FBS)Àº ÀӽŠ6°³¿ù°æ¿¡ µµÃàµÈ ÀÓ½ÅÇÑ ¼Ò¿¡¼­ äÃëÇÑ ÅÂ¾Æ Ç÷¾×¿¡¼­ ÃßÃâÇÑ ÅÂ¾Æ Ç÷¾× ¼¼Æ÷¿¡¼­ ÃßÃâÇÑ ¼¼Æ÷¿¡¼­ À¯·¡ÇÕ´Ï´Ù. ¼ÒžÆÇ÷û(FBS)¿¡´Â ¼¼Æ÷ÀÇ »ýÁ¸, ¼ºÀå, Áõ½Ä¿¡ ÇʼöÀûÀÎ ´Ù¾çÇÑ ¼ºÀåÀÎÀÚ, ´Ü¹éÁú, ºÎÂøÀÎÀÚ, ºñŸ¹ÎÀÌ ÇÔÀ¯µÇ¾î ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ¼¼Æ÷¸¦ ÀÌ¿ëÇÑ ¿¬±¸¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ Àü ¼¼°è ¼ÒžÆÇ÷û ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è ¼ÒžÆÇ÷û ½ÃÀåÀÇ ¼ºÀåÀº ¹ÙÀÌ¿ÀÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í »ý¸í°úÇÐ »ê¾÷ÀÇ ¿¬±¸ Ȱµ¿ Áõ°¡·Î ÀÎÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰ »ý»êÀº ÃÖÀûÀÇ ¼¼Æ÷¹è¾ç Á¶°ÇÀ» À°¼ºÇϰí À¯ÁöÇϱâ À§ÇØ ¼Ò ÅÂ¾Æ ¼¼·³¿¡ Å©°Ô ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¼ÒžÆÇ÷ûÀ» ÀÌ¿ëÇÑ ±¤¹üÀ§ÇÑ ¿¬±¸ Ȱµ¿À» ÇÊ¿ä·Î ÇÏ´Â ½Å¾à °³¹ß¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª Ãà»ê¾÷ÀÇ °¡°Ý º¯µ¿°ú µ¿¹° º¹Áö °üÇà¿¡ ´ëÇÑ À±¸®Àû ¿ì·Á´Â ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹«Ç÷û ¹× Á¦³ëÇÁ¸® ¼¼Æ÷¹è¾ç ¹èÁö·ÎÀÇ ÀüȯÀº ¼ÒžÆÇ÷û ½ÃÀå¿¡ µµÀüÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ¸ÂÃãÇü ÀÇ·á, Àç»ý Ä¡·á, Áٱ⼼Æ÷ ¿¬±¸¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¿¹Ãø ±â°£ µ¿¾È Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» ¿¬±¸ÀÇ ÁÖ¿ä Æ¯Â¡

ÀÌ º¸°í¼­´Â 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAG%)À» ºÐ¼®ÇÏ¿© Àü ¼¼°è ¼ÒžÆÇ÷û ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®ÇÕ´Ï´Ù.

¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ÆÄ¾ÇÇϰí, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á»çÇ×µµ Á¦°øÇÕ´Ï´Ù.

¼¼°è ¼ÒžÆÇ÷û ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ½ÇÀû, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ÀÛ¼ºµÇ¾ú½À´Ï´Ù.

ÁÖ¿ä ±â¾÷À¸·Î´Â Merck KGaA, Thermo Fisher Scientific Inc, HiMedia Laboratories, Bio-Techne, PAN-Biotech, Atlas Biologicals, Inc. Biologicals, Cytiva, Sartorius AG, SeraCare Life Sciences µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¼ÒžÆÇ÷û ½ÃÀåÀ» ºÐ¼®ÇÒ ¶§ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ºÐ¼® ¸ñÀû°ú °¡Á¤

  • ºÐ¼® ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ¿ªÇС¤±ÔÁ¦¡¤µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° ¹ß¸Å/½ÂÀÎ
  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ±â¾÷ ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À
  • ½ÃÀå µ¿Çâ

Á¦4Àå ¼¼°èÀÇ ¼ÒžÆÇ÷û ½ÃÀå : ¿ëµµº°, 2019-2031³â(10¾ï ´Þ·¯)

  • Drug Discovery
  • ü¿Ü¼öÁ¤
  • ¹é½Å Á¦Á¶
  • ¼¼Æ÷ ±â¹Ý ¿¬±¸
  • Áø´Ü
  • ±âŸ

Á¦5Àå ¼¼°èÀÇ ¼ÒžÆÇ÷û ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, 2019-2031³â(10¾ï ´Þ·¯)

  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • CRO(ÀǾàǰ ÀÓ»ó½ÃÇè¼öʱâ°ü)
  • Çмú¿¬±¸±â°ü
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ¼ÒžÆÇ÷û ½ÃÀå : Áö¿ªº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦7Àå °æÀï ±¸µµ

  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • HiMedia Laboratories
  • Bio-Techne
  • PAN-Biotech
  • Atlas Biologicals, Inc.
  • Rocky Mountain Biologicals
  • Cytiva
  • Sartorius AG
  • SeraCare Life Sciences

Á¦8Àå ¾Ö³Î¸®½ºÆ®ÀÇ Á¦¾È

  • Wheel of Fortune
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
  • Coherent Opportunity Map(COM)

Á¦9Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í¹®Çå
  • ºÐ¼® ¹æ¹ý
  • Coherent Market Insights¿¡ ´ëÇØ
ksm 24.12.23

The fetal bovine serum market is estimated to be valued at USD 1.86 Bn in 2024 and is expected to reach USD 4.54 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.6% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: 1.86 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 13.60% 2031 Value Projection: 4.54 Bn
Figure. Fetal Bovine Serum Market Share (%), By Region, 2024
Fetal Bovine Serum Market - IMG1

Fetal bovine serum is an important cell culture media supplement used in scientific research and various medical processes. It is derived from fetal blood cells obtained from fetal blood collected from slaughtered pregnant cattle around 6 months of gestation. Fetal bovine serum (FBS) contains various growth factors, proteins, attachment factors, and vitamins essential for cell survival, growth, and proliferation. The increasing demand for biopharmaceuticals and rising focus on cell-based research is driving the growth of the fetal bovine serum market globally.

Market Dynamics:

The global fetal bovine serum market growth is driven by the rising demand for biopharmaceuticals and increasing research activities in life science industries. Biopharmaceutical production heavily relies on fetal bovine serum for growing and maintaining optimal cell culture conditions. Rising prevalence of chronic diseases is propelling the demand for new drug development which requires extensive research activities utilizing fetal bovine serum. However, price fluctuations in cattle farming and ethical concerns regarding animal welfare practices could hamper the market growth. Also, a shift towards serum-free and xeno-free cell culture mediums presents challenges to the fetal bovine serum market. Nonetheless, the growing focus on personalized medicine, regenerative therapies, and stem cell research are expected to present significant growth opportunities over the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global fetal bovine serum market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global fetal bovine serum market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific Inc., HiMedia Laboratories, Bio-Techne, PAN-Biotech, Atlas Biologicals, Inc., Rocky Mountain Biologicals, Cytiva, Sartorius AG, and SeraCare Life Sciences

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global fetal bovine serum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fetal bovine serum market

Market Segmentation

  • Application Insights (Revenue, USD Bn, 2019 - 2031)
    • Drug Discovery
    • In-vitro Fertilization
    • Vaccine Production
    • Cell-based Research
    • Diagnosis
    • Others
  • End User Insights (Revenue, USD Bn, 2019 - 2031)
    • Pharmaceutical & Biotechnology Companies
    • Contract Research Organizations (CRO)
    • Academic And Research Institutes
    • Others
  • Regional Insights (Revenue, USD Bn, 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • HiMedia Laboratories
    • Bio-Techne
    • PAN-Biotech
    • Atlas Biologicals, Inc.
    • Rocky Mountain Biologicals
    • Cytiva
    • Sartorius AG
    • SeraCare Life Sciences

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Fetal Bovine Serum Market, By Application
    • Fetal Bovine Serum Market, By End User
    • Fetal Bovine Serum Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Market Trends

4. Global Fetal Bovine Serum Market, By Application, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • In-vitro Fertilization
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Vaccine Production
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Cell-based Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Fetal Bovine Serum Market, By End User, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Contract Research Organizations (CRO)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Academic And Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Fetal Bovine Serum Market, By Region, 2019 - 2031, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

7. Competitive Landscape

  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • HiMedia Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Techne
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PAN-Biotech
  • Atlas Biologicals, Inc.
  • Rocky Mountain Biologicals
  • Cytiva
  • Sartorius AG
  • SeraCare Life Sciences

8. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

9. References and Research Methodology

  • References
  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦